Sign Out
Use with other vaccines: Arexvy may be administered concomitantly with seasonal influenza vaccine (quadrivalent, standard dose, unadjuvanted, inactivated). In a randomised study in adults 60 years of age and older, the criteria for non-inferiority of the immune responses in the co-administration versus the separate administration group were met. However, numerically lower RSV A and B neutralising titres and numerically lower influenza A and B haemagglutination inhibition titres were observed when Arexvy and inactivated seasonal influenza vaccine were co-administered than when they were administered separately. The clinical relevance of this finding is unknown. There are no data on co-administration with high dose or adjuvanted seasonal influenza vaccines.
If Arexvy is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites.
Concomitant administration of Arexvy with other vaccines has not been studied.
